Clinical Trial Update: Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) [Phase 3]

View source ↗

Summary

This Phase 3 trial comparing posaconazole prophylaxis against standard azole therapy in neutropenic patients has completed. It includes patients with acute myel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Neutropenia

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Leukemia, Myelocytic, Acute, Myelodysplastic Syndromes | Phase 3 | Status: COMPLETED